Asia Pacific Newborn Screening Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Asia Pacific Newborn Screening Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Newborn screening has evolved from a simple urine or blood screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions. Newborn screening tests measure a number of markers in infant’s blood that can be either decreased or increased if an infant has certain diseases. Currently, conditions such as cystic fibrosis (CF), congenital hypothyroidism, phenylketonuria (PKU), and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed through newborn screening tests.

Market Dynamics

Demand for newborn screening is increasing in order to tackle various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million infants are unvaccinated resulting in death of 2-3 million children every year.

Screening of newborn is rapidly gaining traction in Asia Pacific region, owing to highest birth rate in the region, which is almost half of the global population. Therefore, countries in Asia Pacific are focusing on arranging various workshops to discuss and find solutions for increasing incidence of neonatal diseases. For instance, from March 30–April 1, 2008, PerkinElmer, Inc. arranged a workshop on consolidating newborn screening efforts in Cebu, Philippines, in Asia Pacific region. From June 4-5 in 2010, PerkinElmer, Inc. arranged another workshop in Manila, Philippines, which included workshop participants such as service providers, policy-makers, consumer advocates, and researchers from 11 different countries.

Key features of the study:

  • This report provides in-depth analysis of the Asia Pacific newborn screening market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the Asia Pacific newborn screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Medtronic plc, Agilent Technologies, Waters Technologies Corporation, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare Pvt. Ltd., and ZenTech S.A.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The Asia Pacific newborn screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for Asia Pacific newborn screening market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Asia Pacific Newborn Screening Market, By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • Asia Pacific Newborn Screening Market, By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • Asia Pacific Newborn Screening Market, By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • Asia Pacific Newborn Screening Market, By Region:
  • China
  • By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • India
  • By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • Japan
  • By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • Australia
  • By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • South Korea
  • By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • ASEAN
  • By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • Rest of Asia Pacific
  • By Product Type:
  • Hearing Screening Devices
  • Mass Spectrometer
  • Pulse Oximetry
  • Assay Kits and Reagents
  • By Test Type:
  • Phenylketonuria (PKU)
  • Critical Congenital Heart Defect (CCHD)
  • Hearing Screening
  • Sickle Cell Disease
  • Maple Syrup Urine Disease (MSUD)
  • Thyroid Disorder
  • Biotinidase Deficiency (BTD)
  • Others
  • By End User:
  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers
  • Company Profiles
  • Medtronic plc*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Bio-rad Laboratories, Inc.
  • GE Healthcare
  • PerkinElmer, Inc.
  • Waters Technologies Corporation
  • Masimo Corporation
  • Natus Medical Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • ZenTech S.A.
  • Agilent Technologies, Inc.
  • Danaher Corporation (AB SCIEX)
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Test Type
Market Snippet, By End User
Market Snippet, By Country
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Merger and Acquisition
Technology Advancements
Product Launches
Government Initiatives
Epidemiology
Product Recalls
Regulatory Scenario
PORTER’S Five Forces
PEST Analysis
4. Asia Pacific Newborn Screening Market, By Product Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hearing Screening Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Mass Spectrometer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Pulse Oximetry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Assay Kits and Reagents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Asia Pacific Newborn Screening Market, By Test Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Phenylketonuria (PKU)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Critical Congenital Heart Defect (CCHD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Hearing Screening
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Sickle Cell Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Maple Syrup Urine Disease (MSUD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Thyroid Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Biotinidase Deficiency (BTD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Asia Pacific Newborn Screening Market, By End User, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Maternity & Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
7. Asia Pacific Newborn Screening Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
China
Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
India
Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Japan
Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Australia
Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
South Korea
Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
ASEAN
Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
Rest of Asia Pacific
Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Test Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
8. Competitive Landscape
Heat Map Analysis
Company Profiles
Medtronic plc
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bio-rad Laboratories, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
GE Healthcare
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
PerkinElmer, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Waters Technologies Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Masimo Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Natus Medical Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Trivitron Healthcare Pvt. Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
ZenTech S.A.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Agilent Technologies, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Danaher Corporation (AB SCIEX)
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 40 figures on “Newborn Screening Market” - Asia Pacific forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook